Silva ECDS, Mantovani MDF, Nogueira LDA, Küchler ML, Cassi CCAV, Kalinke LP. Financial toxicity in people with chronic kidney disease undergoing hemodialysis treatment.
Rev Bras Enferm 2023;
76:e20220671. [PMID:
37672464 PMCID:
PMC10476517 DOI:
10.1590/0034-7167-2022-0671]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 02/12/2023] [Indexed: 09/08/2023] Open
Abstract
OBJECTIVE
to assess the financial toxicity of people with chronic kidney disease undergoing hemodialysis treatment.
METHOD
a descriptive analytical cross-sectional study, carried out with 214 people, between February and May 2022. For data collection, a sociodemographic and clinical instrument and the COmprehensive Score for financial Toxicity were used. For analysis, the Odds Ratio, ANOVA and Cronbach's alpha tests were used.
RESULTS
the mean financial toxicity score was 20.30. Women with a monthly family income of at most two minimum wages are more likely to have some degree of financial toxicity (Odds Ratio: 0.85; 0.76).
CONCLUSION
financial toxicity was identified to different degrees and varied according to sociodemographic and clinical characteristics. Measuring financial toxicity can help nurses plan care and develop strategies to avoid interrupting treatment.
Collapse